Evidence map›Paper›PMID 31963163›Full record

Trial reportNutrients2020

Low Plasma Appearance of (+)-Catechin and (-)-Catechin Compared with Epicatechin after Consumption of Beverages Prepared from Nonalkalized or Alkalized Cocoa-A Randomized, Double-Blind Trial.

Sabine Ellinger, Andreas Reusch, Lisa Henckes, Christina Ritter, Benno F Zimmermann, Jörg Ellinger, Rudolf Galensa, Peter Stehle, Hans-Peter Helfrich

Open access · goldAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Sabine EllingerFaculty of Food, Nutrition and Hospitality Sciences, Hochschule Niederrhein, University of Applied Sciences, Rheydter Str. 277, 41065 Mönchengladbach, Germany.ORCID 0000-0002-9988-9406
Andreas ReuschInstitute of Nutritional and Food Sciences, Nutritional Physiology, University of Bonn, Nußallee 9, 53115 Bonn, Germany.
Lisa HenckesInstitute of Nutritional and Food Sciences, Food Sciences, University of Bonn, Endenicher Allee 11-13, 53115 Bonn, Germany.
Christina RitterInstitute of Nutritional and Food Sciences, Food Sciences, University of Bonn, Endenicher Allee 11-13, 53115 Bonn, Germany.
Benno F ZimmermannInstitute of Nutritional and Food Sciences, Food Sciences, University of Bonn, Endenicher Allee 11-13, 53115 Bonn, Germany.ORCID 0000-0002-9877-7066
Jörg EllingerDepartment of Urology and Children Urology, University Hospital Bonn, Sigmund-Freud-Str. 25, 53127 Bonn, Germany.ORCID 0000-0002-7526-0857
Rudolf GalensaInstitute of Nutritional and Food Sciences, Food Sciences, University of Bonn, Endenicher Allee 11-13, 53115 Bonn, Germany.
Peter StehleInstitute of Nutritional and Food Sciences, Nutritional Physiology, University of Bonn, Nußallee 9, 53115 Bonn, Germany.ORCID 0000-0002-4596-8088
Hans-Peter HelfrichInstitute of Numerical Simulation, University of Bonn, Endenicher Allee 60, 53115 Bonn, Germany.
University of Bonn · DEUniversity Hospital Bonn · DE

Funding

Institute Danone Nutrition for Health 2009/19
6 · The paper itself

Abstract

Flavan-3-ols are claimed to be responsible for the cardioprotective effects of cocoa. Alkalized cocoa powder (ALC), commonly used for many non-confectionary products, including beverages, provides less (+)-catechin, (-)-epicatechin, and procyanidins and more (-)-catechin than nonalkalized cocoa powder (NALC). This may affect the plasma appearance of monomeric flavan-3-ol stereoisomers after consumption of NALC vs. ALC. Within a randomized, crossover trial, 12 healthy nonsmokers ingested a milk-based cocoa beverage providing either NALC or ALC. Blood was collected before and within 6 h postconsumption. (+)-Catechin, (-)-catechin, and epicatechin were analyzed in plasma by HPLC as sum of free and glucuronidated metabolites. Pharmacokinetic parameters were obtained by a one-compartment model with nonlinear regression methods. For epicatechin in plasma, total area under the curve within 6 h postconsumption (

Indexed as

BeveragesChocolateAdultCatechinCross-Over StudiesDouble-Blind MethodFemaleGermanyHealthy VolunteersHumansHydrogen-Ion ConcentrationMaleModels, BiologicalNonlinear DynamicsPilot ProjectsYoung AdultCatechin(+)-catechin(−)-catechinchiral separationcocoa(−)-epicatechinflavan-3-ol stereoisomersone-compartment modelpharmacokineticsplasma appearance

Identifiers

PMID31963163
PMCPMC7020035
OpenAlexW2998867579

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.